Granahan Investment Management - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$2,918,499
-49.7%
1,552,393
-4.0%
0.10%
-41.9%
Q2 2023$5,803,547
+9.9%
1,616,587
+3.1%
0.18%
+11.2%
Q1 2023$5,282,610
+113.8%
1,567,540
-1.6%
0.16%
+111.8%
Q4 2022$2,470,252
+20.2%
1,593,711
+5.5%
0.08%
+13.4%
Q3 2022$2,055,000
-32.2%
1,511,029
+9.2%
0.07%
-35.6%
Q2 2022$3,031,000
-21.9%
1,384,014
+13.8%
0.10%
+8.3%
Q1 2022$3,879,000
-16.3%
1,215,928
+10.0%
0.10%
+1.1%
Q4 2021$4,632,000
-50.6%
1,105,607
-4.2%
0.10%
-46.6%
Q3 2021$9,375,000
+23.7%
1,154,561
+15.0%
0.18%
+26.2%
Q2 2021$7,577,000
-4.3%
1,003,546
+10.0%
0.14%
-16.1%
Q1 2021$7,917,000
+23.0%
912,154
+12.9%
0.17%
+16.7%
Q4 2020$6,437,000
+27.7%
807,699
+27.8%
0.14%
-15.8%
Q3 2020$5,040,000
-13.6%
632,035
+7.2%
0.17%
-19.0%
Q2 2020$5,836,000
+9.2%
589,483
-14.7%
0.21%
-26.7%
Q1 2020$5,342,000
+104.4%
691,130
+1.8%
0.29%
+140.0%
Q4 2019$2,613,000
-21.8%
678,618
+2.1%
0.12%
-34.8%
Q3 2019$3,343,000
+27.7%
664,704
+67.9%
0.18%
+42.6%
Q2 2019$2,617,000
+6.2%
395,875
+21.6%
0.13%
-2.3%
Q1 2019$2,465,000
+9.7%
325,652
+17.1%
0.13%
-17.0%
Q4 2018$2,248,000
-7.0%
278,170
+48.5%
0.16%
+21.4%
Q3 2018$2,416,000187,3000.13%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders